blood transfusion: rethinking who, what and when
DESCRIPTION
Blood TransfusionTRANSCRIPT
![Page 1: Blood Transfusion: Rethinking who, what and when](https://reader036.vdocument.in/reader036/viewer/2022081413/5492ddbab47959ab748b4886/html5/thumbnails/1.jpg)
Blood transfusion: rethinking who, what and when
Dr Rebecca HowmanConsultant Haematologist
9th October 2014
![Page 2: Blood Transfusion: Rethinking who, what and when](https://reader036.vdocument.in/reader036/viewer/2022081413/5492ddbab47959ab748b4886/html5/thumbnails/2.jpg)
Blood transfusion practice
• Blood is unique treatment
– It’s a gift: voluntary donors
– It’s complex:Australian Red Cross Blood ServiceTGAhospitalslaboratoriesclinicianspatients
![Page 3: Blood Transfusion: Rethinking who, what and when](https://reader036.vdocument.in/reader036/viewer/2022081413/5492ddbab47959ab748b4886/html5/thumbnails/3.jpg)
Evolution of transfusion
![Page 4: Blood Transfusion: Rethinking who, what and when](https://reader036.vdocument.in/reader036/viewer/2022081413/5492ddbab47959ab748b4886/html5/thumbnails/4.jpg)
Transfusion practice in 21st century
Transfusion guidelines from NHMRC
• >100 g/L transfusion prob not good• <70 g/L transfusion prob good• 70-100 g/L …you decide
“If you have decided the patient needs one unit, then you might as well give two”“You need a blood transfusion.”….”Do I?”
![Page 5: Blood Transfusion: Rethinking who, what and when](https://reader036.vdocument.in/reader036/viewer/2022081413/5492ddbab47959ab748b4886/html5/thumbnails/5.jpg)
Transfusion for anaemia in non-bleeding (or “stabilised recently bleeding”) patient
• We have assumed for too long that transfusion is safe, beneficial and free
• In anaemic patients– ?does an increase in Hb equate to improved patient
symptoms, improved patient outcomes– ?at what threshold is the clinical benefit– ?is there any harm
![Page 6: Blood Transfusion: Rethinking who, what and when](https://reader036.vdocument.in/reader036/viewer/2022081413/5492ddbab47959ab748b4886/html5/thumbnails/6.jpg)
Perils of anaemia
Perils of transfusion
![Page 7: Blood Transfusion: Rethinking who, what and when](https://reader036.vdocument.in/reader036/viewer/2022081413/5492ddbab47959ab748b4886/html5/thumbnails/7.jpg)
Anaemia increases risk of death
![Page 8: Blood Transfusion: Rethinking who, what and when](https://reader036.vdocument.in/reader036/viewer/2022081413/5492ddbab47959ab748b4886/html5/thumbnails/8.jpg)
![Page 9: Blood Transfusion: Rethinking who, what and when](https://reader036.vdocument.in/reader036/viewer/2022081413/5492ddbab47959ab748b4886/html5/thumbnails/9.jpg)
OR for each 10g/L decrease 2.1 (1.7-2.6)No sig interaction between Hb and CVS disease (p-0.09)
![Page 10: Blood Transfusion: Rethinking who, what and when](https://reader036.vdocument.in/reader036/viewer/2022081413/5492ddbab47959ab748b4886/html5/thumbnails/10.jpg)
Risk of death in those who refuse Tx
![Page 11: Blood Transfusion: Rethinking who, what and when](https://reader036.vdocument.in/reader036/viewer/2022081413/5492ddbab47959ab748b4886/html5/thumbnails/11.jpg)
![Page 12: Blood Transfusion: Rethinking who, what and when](https://reader036.vdocument.in/reader036/viewer/2022081413/5492ddbab47959ab748b4886/html5/thumbnails/12.jpg)
Overall median days from lowest Hb to death 2d (range 0-22, IQR 1-8)
![Page 13: Blood Transfusion: Rethinking who, what and when](https://reader036.vdocument.in/reader036/viewer/2022081413/5492ddbab47959ab748b4886/html5/thumbnails/13.jpg)
Perils of blood transfusion
![Page 14: Blood Transfusion: Rethinking who, what and when](https://reader036.vdocument.in/reader036/viewer/2022081413/5492ddbab47959ab748b4886/html5/thumbnails/14.jpg)
Why transfuse?
• Patients are transfused to treat symptoms, reduce morbidity and mortality, and improve quality of life
• Delivery of oxygen to tissue is the primary function of the RBC…transfusion must be to improve tissue oxygen delivery (not oxygen carrying capacity).
• Other reasons for transfusion (volume expansion, support for blood pressure) are not promoted
![Page 15: Blood Transfusion: Rethinking who, what and when](https://reader036.vdocument.in/reader036/viewer/2022081413/5492ddbab47959ab748b4886/html5/thumbnails/15.jpg)
Poor O2 dissociation
• Normal RBC P50 26mmHg
• Stored RBC quickly loses 2,3 DPG, by 48-96h storage, 2,3 DPG virtually zero (P50 6-11mmHg)
• Transfused blood has such a high affinity that it does not release O2, may well pull O2 from tissues
• Transfused blood will begin 2,3 DPG repletion after rewarming…by 24 hours levels are still <50% normal
![Page 16: Blood Transfusion: Rethinking who, what and when](https://reader036.vdocument.in/reader036/viewer/2022081413/5492ddbab47959ab748b4886/html5/thumbnails/16.jpg)
Red cell membrane changes
![Page 17: Blood Transfusion: Rethinking who, what and when](https://reader036.vdocument.in/reader036/viewer/2022081413/5492ddbab47959ab748b4886/html5/thumbnails/17.jpg)
Immune modulation• Transfusion attenuates immune response
– Improve renal allograft survival– Reduce risk of recurrent spontaneous abortion– Reduce severity of autoimmune disorders– Increase cancer recurrence– Increase peri-operative infections– Increase multi-organ failure
• Mechanisms?– Reduction in CD8 T-cell function and number– Altered CD4 number– NK cell number and function– Macrophage-mediated– Cell mediated responses
![Page 18: Blood Transfusion: Rethinking who, what and when](https://reader036.vdocument.in/reader036/viewer/2022081413/5492ddbab47959ab748b4886/html5/thumbnails/18.jpg)
Recognition of risks of blood transfusion
• Risks of blood transfusion go beyond transmission of infection, fever, incomptability reactions etc
• Blood transfusion is associated with worse patient outcomes – Increased post-operative infection (immune modulation)– Increased length of stay– Increased thrombosis rate– Increased cancer recurrence– Increased mortality in short term
![Page 19: Blood Transfusion: Rethinking who, what and when](https://reader036.vdocument.in/reader036/viewer/2022081413/5492ddbab47959ab748b4886/html5/thumbnails/19.jpg)
Blood Budget
• Blood is freely given but it is not free!• $350 per unit red cells from ARBCS• $650-1000 per unit = administration,
transport, hospital costs
• Future (2016)– blood budget is to be devolved to hospitals
![Page 20: Blood Transfusion: Rethinking who, what and when](https://reader036.vdocument.in/reader036/viewer/2022081413/5492ddbab47959ab748b4886/html5/thumbnails/20.jpg)
![Page 21: Blood Transfusion: Rethinking who, what and when](https://reader036.vdocument.in/reader036/viewer/2022081413/5492ddbab47959ab748b4886/html5/thumbnails/21.jpg)
Patient Blood Management (PBM)
The timely application of evidence-based medical and surgical concepts designed to maintain hemoglobin concentration, optimize hemostasis and minimize blood loss in an effort to improve patient outcome.
![Page 22: Blood Transfusion: Rethinking who, what and when](https://reader036.vdocument.in/reader036/viewer/2022081413/5492ddbab47959ab748b4886/html5/thumbnails/22.jpg)
![Page 23: Blood Transfusion: Rethinking who, what and when](https://reader036.vdocument.in/reader036/viewer/2022081413/5492ddbab47959ab748b4886/html5/thumbnails/23.jpg)
PBM in WA• 3.9% hospital separations in 2012-2013 were associated with a
transfusion
• DoH in WA has been implemented Patient Blood Management– FH 2008– SCGH mid-2012 – RPH, KEMH 2013
• PBM staff provide – education regarding risks and benefits of transfusion– advocate alternatives to transfusion e.g. IV iron– initiate and advocate for hospital policies that support the appropriate use of
blood and blood products– develop innovations such as paediatric tubes, Rotem, etc
![Page 24: Blood Transfusion: Rethinking who, what and when](https://reader036.vdocument.in/reader036/viewer/2022081413/5492ddbab47959ab748b4886/html5/thumbnails/24.jpg)
Single unit transfusion policy at SCGH
Why give 2, when 1 will
do?•In many instances a transfusion of one unit of red cells will be sufficient to improve symptoms
• A second unit should only be prescribed following review of the patient
![Page 25: Blood Transfusion: Rethinking who, what and when](https://reader036.vdocument.in/reader036/viewer/2022081413/5492ddbab47959ab748b4886/html5/thumbnails/25.jpg)
3165
4967
2863
3923
Reduction of 1044 units
(21%) transfused
Comparison of pre- and post-single unit policy
![Page 26: Blood Transfusion: Rethinking who, what and when](https://reader036.vdocument.in/reader036/viewer/2022081413/5492ddbab47959ab748b4886/html5/thumbnails/26.jpg)
1707
2065
1227
646
231172
Comparison of pre- and post-single unit policy
![Page 27: Blood Transfusion: Rethinking who, what and when](https://reader036.vdocument.in/reader036/viewer/2022081413/5492ddbab47959ab748b4886/html5/thumbnails/27.jpg)
360
233
956
54724%
reduction
43% reduction
Comparison of pre- and post-single unit policy
![Page 28: Blood Transfusion: Rethinking who, what and when](https://reader036.vdocument.in/reader036/viewer/2022081413/5492ddbab47959ab748b4886/html5/thumbnails/28.jpg)
Overall “value”
• Cost savings: significant– $361,570 saved (RBC price)– $2-3.6 million (total transfusion price)
• Patient outcomes….???– Length of stay– Infection rate– Readmission rates
![Page 29: Blood Transfusion: Rethinking who, what and when](https://reader036.vdocument.in/reader036/viewer/2022081413/5492ddbab47959ab748b4886/html5/thumbnails/29.jpg)
What can you do instead? Go to PBM intranet site
• Intravenous iron– iron carboxymaltose (1000mg given over 15 mins)
• on hospital formulary for IV lounge, AAU• cost PBS $317 per 500mg
– iron polymaltose (1000mg given over 5 hours)• $150 per 500mg
• Oral iron (specify formulation)– FGF, Ferrogradumet, Ferrograd C, Ferro-f-tab
• Non-iron anaemia– end consult (haem, renal, general med)
![Page 30: Blood Transfusion: Rethinking who, what and when](https://reader036.vdocument.in/reader036/viewer/2022081413/5492ddbab47959ab748b4886/html5/thumbnails/30.jpg)
Transfusion Sample Collection
Results & Strategies
![Page 31: Blood Transfusion: Rethinking who, what and when](https://reader036.vdocument.in/reader036/viewer/2022081413/5492ddbab47959ab748b4886/html5/thumbnails/31.jpg)
Sample collection Errors August 2014
![Page 32: Blood Transfusion: Rethinking who, what and when](https://reader036.vdocument.in/reader036/viewer/2022081413/5492ddbab47959ab748b4886/html5/thumbnails/32.jpg)
• Governed by National Guidelines for Pre-Transfusion Pathology requirements– National Pathology Accreditation Advisory Council (NPAAC)– Australia and New Zealand Society of Blood Transfusion
guidelines
Following collection and before leaving the patient, the sample tube(s) must be legibly labelled with the: Patient’s family name, first name in full Hospital record number or date of birth Date & time of collection Signature [or initials] of the collector”
Sample collection & labelling requirements
![Page 33: Blood Transfusion: Rethinking who, what and when](https://reader036.vdocument.in/reader036/viewer/2022081413/5492ddbab47959ab748b4886/html5/thumbnails/33.jpg)
Strategies
• 3 policy posters • Correct Completion of Transfusion Request Forms• Rhyme poster as a reminder to check for date, time and
signature• Policy rationales
• Education sessions– Session with ED nurses– Have competition for medical staff
• Suggest recommendations on how transfusion services can improve services for staff
![Page 34: Blood Transfusion: Rethinking who, what and when](https://reader036.vdocument.in/reader036/viewer/2022081413/5492ddbab47959ab748b4886/html5/thumbnails/34.jpg)
1st Poster 2nd Poster
![Page 35: Blood Transfusion: Rethinking who, what and when](https://reader036.vdocument.in/reader036/viewer/2022081413/5492ddbab47959ab748b4886/html5/thumbnails/35.jpg)
3rd Poster
![Page 36: Blood Transfusion: Rethinking who, what and when](https://reader036.vdocument.in/reader036/viewer/2022081413/5492ddbab47959ab748b4886/html5/thumbnails/36.jpg)
• Checklists for trolleys– SCGH Checklist for Specimen Collection
• Group & Screen and Crossmatch Blood Samples
![Page 37: Blood Transfusion: Rethinking who, what and when](https://reader036.vdocument.in/reader036/viewer/2022081413/5492ddbab47959ab748b4886/html5/thumbnails/37.jpg)